HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Supplemental Data All Versions of this Article: M700271-MCP200v1 7/3/560    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Glossary Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Abu-Farha, M. Articles by Figeys, D. Search for Related Content PubMed PubMed Citation Articles by Abu-Farha, M. Articles by Figeys, D. Social Bookmarking                      What's this?

Molecular & Cellular Proteomics 7:560-572, 2008.
© 2008 by The American Society for Biochemistry and Molecular Biology, Inc.

---

Research

The Tale of Two Domains

Proteomics and Genomics Analysis of SMYD2, A New Histone Methyltransferase^*,S

Mohamed Abu-Farha^,, Jean-Philippe Lambert^,, Ashraf S. Al-Madhoun^,¶, Fred Elisma, Ilona S. Skerjanc^,|| and Daniel Figeys^,,**

From the Ottawa Institute of Systems Biology and Department of Biochemistry, Microbiology, and Immunology, University of Ottawa, Ottawa, Ontario K1H 8M5, Canada

Very little is known about SET- and MYND-containing protein 2 (SMYD2), a member of the SMYD protein family. However, the interest in better understanding the roles of SMYD2 has grown because of recent reports indicating that SMYD2 methylates p53 and histone H3. In this study, we present a combined proteomics and genomics study of SMYD2 designed to elucidate its molecular roles. We report the cytosolic and nuclear interactome of SMYD2 using a combination of immunoprecipitation coupled with high throughput MS, chromatin immunoprecipitation coupled with high throughput MS, and co-immunoprecipitation methods. In particular, we report that SMYD2 interacted with HSP90 independently of the SET and MYND domains, with EBP41L3 through the MYND domain, and with p53 through the SET domain. We demonstrated that the interaction of SMYD2 with HSP90 enhances SMYD2 histone methyltransferase activity and specificity for histone H3 at lysine 4 (H3K4) in vitro. Interestingly histone H3K36 methyltransferase activity was independent of its interaction with HSP90 similar to LSD1 dependence on the androgen receptor. We also showed that the SET domain is required for the methylation at H3K4. We demonstrated using a modified chromatin immunoprecipitation protocol that the SMYD2 gain of function leads to an increase in H3K4 methylation in vivo, whereas no observable levels of H3K36 were detected. We also report that the SMYD2 gain of function was correlated with the up-regulation of 37 and down-regulation of four genes, the majority of which are involved in the cell cycle, chromatin remodeling, and transcriptional regulation. TACC2 is one of the genes up-regulated as a result of SMYD2 gain of function. Up-regulation of TACC2 by SMYD2 occurred as a result of SMYD2 binding to the TACC2 promoter where it methylates H3K4. Furthermore the combination of the SMYD2 interactome with the gene expression data suggests that some of the genes regulated by SMYD2 are closely associated with SMYD2-interacting proteins.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				M. Berdasco, S. Ropero, F. Setien, M. F. Fraga, P. Lapunzina, R. Losson, M. Alaminos, N.-K. Cheung, N. Rahman, and M. Esteller Epigenetic inactivation of the Sotos overgrowth syndrome gene histone methyltransferase NSD1 in human neuroblastoma and glioma PNAS, December 22, 2009; 106(51): 21830 - 21835. [Abstract] [Full Text] [PDF]

				S. Komatsu, I. Imoto, H. Tsuda, K.-i. Kozaki, T. Muramatsu, Y. Shimada, S. Aiko, Y. Yoshizumi, D. Ichikawa, E. Otsuji, et al. Overexpression of SMYD2 relates to tumor cell proliferation and malignant outcome of esophageal squamous cell carcinoma Carcinogenesis, July 1, 2009; 30(7): 1139 - 1146. [Abstract] [Full Text] [PDF]